CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

ray1225

Peptideexperimental

Clinical trial activity

9 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
5
Phase 3
3
Phase 4
0

Earliest trial started May 18, 2023 (NCT05835752)

Timeline

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2024

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07139535Phase 3Aug 31, 2025Guangdong Raynovent Biotech Co., Ltd
NCT07139548Phase 3Aug 31, 2025Guangdong Raynovent Biotech Co., Ltd
NCT06893016Phase 3Jun 15, 2025Guangdong Raynovent Biotech Co., Ltd
NCT06613763Phase 1Sep 11, 2024Guangdong Raynovent Biotech Co., Ltd
NCT06577415Phase 1Aug 26, 2024Guangdong Raynovent Biotech Co., Ltd
NCT06577428Phase 1Jul 30, 2024Guangdong Raynovent Biotech Co., Ltd
NCT06254274Phase 2Feb 26, 2024Guangdong Raynovent Biotech Co., Ltd
NCT06254261Phase 2Feb 21, 2024Guangdong Raynovent Biotech Co., Ltd
NCT05835752Phase 1May 18, 2023Guangdong Raynovent Biotech Co., Ltd
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Guangdong Raynovent Biotech Co., LtdFor profit9932023
1 organizations
Page 1 / 1